Academic Journal
Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial
| Τίτλος: | Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial |
|---|---|
| Συγγραφείς: | Weidhase, Lorenz, de Fallois, Jonathan, Haußig, Elena, Kaiser, Thorsten, Mende, Meinhard, Petros, Sirak |
| Πηγή: | http://lobid.org/resources/99370670818906441#!, 24(1):644. |
| Έτος έκδοσης: | 2020 |
| Συλλογή: | Publisso (ZB MED-Publikationsportal Lebenswissenschaften) |
| Θεματικοί όροι: | EMiC2, Urea/analysis [MeSH], Aged [MeSH], Renal Dialysis/methods [MeSH], Renal replacement therapy, Critical Illness [MeSH], Urea/blood [MeSH], Renal Dialysis/statistics, Male [MeSH], Creatinine/blood [MeSH], High cutoff dialyzer, Metabolic Clearance Rate/physiology [MeSH], Rhabdomyolysis, Creatinine/analysis [MeSH], Female [MeSH], Myoglobin/blood [MeSH], Myoglobin/physiology [MeSH], Kaplan-Meier Estimate [MeSH], Humans [MeSH], Prospective Studies [MeSH], Myoglobin/metabolism [MeSH], Middle Aged [MeSH], Acute kidney injury, Research, Myoglobin clearance |
| Περιγραφή: | Background!#!Myoglobin clearance in acute kidney injury requiring renal replacement therapy is important because myoglobin has direct renal toxic effects. Clinical data comparing different modalities of renal replacement therapy addressing myoglobin clearance are limited. This study aimed to compare two renal replacement modalities regarding myoglobin clearance.!##!Methods!#!In this prospective, randomized, single-blinded, single-center trial, 70 critically ill patients requiring renal replacement therapy were randomized 1:1 into an intervention arm using continuous veno-venous hemodialysis with high cutoff dialyzer and a control arm using continuous veno-venous hemodiafiltration postdilution with high-flux dialyzer. Regional citrate anticoagulation was used in both groups to maintain the extracorporeal circuit. The concentrations of myoglobin, urea, creatinine, β2-microglobulin, interleukin-6 and albumin were measured before and after the dialyzer at 1 h, 6 h, 12 h, 24 h and 48 h after initiating continuous renal replacement therapy.!##!Results!#!Thirty-three patients were allocated to the control arm (CVVHDF with high-flux dialyzer) and 35 patients to the intervention arm (CVVHD with high cutoff dialyzer). Myoglobin clearance, as a primary endpoint, was significantly better in the intervention arm than in the control arm throughout the whole study period. The clearance values for urea and creatinine were higher in the control arm. There was no measurable albumin clearance in both arms. The clearance data for β!##!Conclusions!#!Myoglobin clearance using continuous veno-venous hemodialysis with high cutoff dialyzer and regional citrate anticoagulation is better than that with continuous veno-venous hemodiafiltration with regional citrate anticoagulation.!##!Trial registration!#!German Clinical Trials Registry (DRKS00012407); date of registration 23/05/2017. https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00012407 . |
| Τύπος εγγράφου: | article in journal/newspaper |
| Γλώσσα: | English |
| ISBN: | 978-9937-0-6708-9 9937-0-6708-1 |
| Relation: | https://repository.publisso.de/resource/frl:6463095; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659077/ |
| DOI: | 10.1186/s13054-020-03366-8 |
| Διαθεσιμότητα: | https://repository.publisso.de/resource/frl:6463095 https://doi.org/10.1186/s13054-020-03366-8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659077/ |
| Rights: | https://creativecommons.org/licenses/by/4.0/ |
| Αριθμός Καταχώρησης: | edsbas.879CF069 |
| Βάση Δεδομένων: | BASE |
καταχωρήστε σχόλιο πρώτοι!